Evidence map›Paper›PMID 41892149›Full record

ReviewBiotech (Basel (Switzerland))2026

Artificial Intelligence and Digital Technology in Cardiovascular Imaging: A Narrative Review.

Constantinos H Papadopoulos, Dimitris Karelas, Christina Floropoulou, Konstantina Tzavida, Dimitrios Oikonomidis, Athanasios Tasoulis, Evangelos Tatsis, Ioannis Kouloulias, Nikolaos P E Kadoglou

Abstract readReview
In one paragraph

Review in Biotech (Basel (Switzerland)), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Constantinos H PapadopoulosEchocardiographic Laboratory, 2nd Cardiology Department, Korgialeneio-Benakeio Red Cross Hospital, 11526 Athens, Greece.ORCID 0000-0002-2566-7173
Dimitris KarelasEchocardiographic Laboratory, 2nd Cardiology Department, Korgialeneio-Benakeio Red Cross Hospital, 11526 Athens, Greece.ORCID 0000-0002-2924-8793
Christina FloropoulouEchocardiographic Laboratory, 2nd Cardiology Department, Korgialeneio-Benakeio Red Cross Hospital, 11526 Athens, Greece.
Konstantina TzavidaEchocardiographic Laboratory, 2nd Cardiology Department, Korgialeneio-Benakeio Red Cross Hospital, 11526 Athens, Greece.
Dimitrios OikonomidisEchocardiographic Laboratory, 2nd Cardiology Department, Korgialeneio-Benakeio Red Cross Hospital, 11526 Athens, Greece.ORCID 0000-0003-0697-6656
Athanasios TasoulisEchocardiographic Laboratory, 2nd Cardiology Department, Korgialeneio-Benakeio Red Cross Hospital, 11526 Athens, Greece.
Evangelos TatsisEchocardiographic Laboratory, 2nd Cardiology Department, Korgialeneio-Benakeio Red Cross Hospital, 11526 Athens, Greece.ORCID 0009-0000-9356-5702
Ioannis KoulouliasEchocardiographic Laboratory, 2nd Cardiology Department, Korgialeneio-Benakeio Red Cross Hospital, 11526 Athens, Greece.
Nikolaos P E KadoglouMedical School, University of Cyprus, 2029 Nicosia, Cyprus.ORCID 0000-0002-7830-3488

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid expansion of digital technologies and artificial intelligence (AI) has profoundly transformed cardiovascular imaging, enabling more precise, efficient, and reproducible assessment of cardiac structure and function. This narrative review summarizes recent advances in AI-driven methods across echocardiography, cardiac computed tomography, cardiac magnetic resonance, and nuclear imaging, with emphasis on image acquisition, automated quantification, and diagnostic and prognostic interpretation. We reviewed contemporary literature describing machine-learning and deep-learning applications for image reconstruction, segmentation, radiomics, and multimodal data integration. Current evidence demonstrates that AI improves image quality, reduces acquisition and analysis time, and enables automated, highly reproducible measurements of chamber volumes, function, tissue characterization, coronary anatomy, and myocardial perfusion, while facilitating advanced pattern recognition for differential diagnosis and risk stratification. Furthermore, digital platforms support remote acquisition, tele-echocardiography, and AI-assisted training of non-expert operators. Despite these advances, challenges remain regarding external validation, generalizability across vendors and populations, explainability, data governance, and regulatory compliance. In conclusion, AI and digital technologies are reshaping cardiovascular imaging by enhancing accuracy, efficiency, and accessibility, but their safe and effective clinical integration requires robust multicenter validation, transparent reporting, and ethical-legal frameworks that ensure trust, equity, and accountability.

Indexed as

artificial intelligencecardiac magnetic resonancecardiovascular imagingcomputed tomographydeep learningdigital healthechocardiographymachine learningnuclear cardiologyradiomics

Identifiers

PMID41892149
PMCPMC13024323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.